Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, is proud and eager to announce FDA 510(k) clearance of the new AccelFix Expandable Cage System

Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, is proud and eager to announce FDA 510(k) clearance of the new AccelFix Expandable Cage System – a sterile-packaged, all-encompassing family of expandable interbody devices, which was launched this month at NASS 2019 in Chicago, Illinois.

The AccelFix Expandable Cage System includes expandable interbody solutions from TLIF/PLIF cages (AccelFix-XT), an expandable lateral interbody (AccelFix-XL), and a ground-breaking, Anterior-to-Psoas expandable interbody specially contoured to avoid the contralateral nerve root (Accelfix-XTP).

The launch of the new expandable interbody devices will be added to a wide range of spinal product portfolio which includes AccelFix 5.5 Rod Spinal Fixation System which earned a FDA clearance earlier this year.